A Subset of Genes Can Distinguish between Bortezomib Responsive Versus Bortezomib Resistant Myeloma

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2015, Vol 5, Issue 10

Abstract

Despite the widespread use of proteasome inhibitors in the treatment of multiple myeloma, the mechanisms of the anti-myeloma activity and the molecular pathways that execute the tumor cell killing are still unknown. In the present work we compared gene expression profile changes in response to bortezomib treatment of cultured bone marrow samples from patients with bortezomib-sensitive versus bortezomib-resistant myeloma. The results showed a pronounced induction of>70 genes including>30 heat shock protein transcripts in both patient groups and therefore debate the anti-tumor action, attributed to the unfolded protein response. In contrast, a subset of 7 genes (MMP12, IL7R, MGST1, C3, CYP27A1, MIR148A and CXXC4) changed only in the samples from the bortezomib-sensitive cases and therefore these tumor-associated genes might serve as predictors of the treatment efficacy, as well as for making of further insights onto the mechanism of action of proteasome inhibitors. In summary, we identified a subset of 7 genes which distinguished in our small series betweensensitive versus resistant tumor cells to bortezomib, which requires further assessment in a larger cohort of patients.

Authors and Affiliations

Yossi Cohen, Odit Gutwein, Osnat Garach- Jehoshua, Adina Bar-Haim, Abraham Kornberg

Keywords

Related Articles

Odontogenic Tumour Patterns- An Introspective Analysis

Odontogenic tumours encompass a diverse group of uncommon tumours that are frequently aggressive in their biological behaviour. They comprise 2.4% of all the lesions biopsied in the dental office. Odontogenic tumours hav...

Characterization of a Trpc6 Transgenic Mouse Associated with Early Onset FSGS

Rationale: Mutations in Transient Receptor Potential Channel 6 (TRPC6) gene are associated with autosomal dominant focal and segmental glomerulosclerosis (FSGS). The majority of the identified mutations affect the ion ch...

Porous Titanium Granules in Treatment of Intra-bony Defects: A Literature Review

Background: This study aimed to do a review on the applications of porous titanium granules (PTG) in periodontal and non-periodontal treatments. Methods: An electronic search was carried out in Google Scholar and PubMed...

Carbonic Anhydrase Inhibition Affect Antioxidant Enzyme Activity in the Blood of STZ Induced Diabetic Rats

Background: Carbonic anhydrase is found in the blood of all vertebrate and thus playing a fundamental role in the maintenance of acid-base homeostasis. Erythrocytes are intrinsically prone to oxidative stress because of...

The Evaluation of Laparoscopic Orchiopexy on the Treatment of Non-palpable Undescended Testes

Objectives: Cryptorchidism is the most frequent birth anomaly in boys with 2-5% prevalence in full term infants. This anomaly is associated with an increased risk of testicular cancer and infertility as well as hernia, t...

Download PDF file
  • EP ID EP347183
  • DOI 10.9734/BJMMR/2015/13421
  • Views 42
  • Downloads 0

How To Cite

Yossi Cohen, Odit Gutwein, Osnat Garach- Jehoshua, Adina Bar-Haim, Abraham Kornberg (2015). A Subset of Genes Can Distinguish between Bortezomib Responsive Versus Bortezomib Resistant Myeloma. Journal of Advances in Medicine and Medical Research, 5(10), 1271-1279. https://europub.co.uk/articles/-A-347183